EPISODE · Aug 26, 2024 · 10 MIN
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-way Comparison from AUGUSTUS
from JACC This Week
Dr. Valentin Fuster discusses the Augustus trial's groundbreaking findings on antithrombotic strategies for atrial fibrillation patients post-acute coronary syndrome or PCI. The study reveals that a regimen of apixaban and a P2Y12 inhibitor—without aspirin—offers superior safety and efficacy, challenging traditional triple therapy approaches.
NOW PLAYING
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-way Comparison from AUGUSTUS
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m